[Coagulation and immunoprotein changes under L-asparaginase therapy].
D000328:Adult; D001215:Asparaginase / Q000009:adverse effects*; D001778:Blood Coagulation Disorders / Q000139:chemically induced*; D001779:Blood Coagulation Factors / Q000032:analysis*; D001798:Blood Proteins / Q000032:analysis*; D002908:Chronic Disease; D005260:Female; D006801:Humans; D007136:Immunoglobulins / Q000032:analysis; D007938:Leukemia / Q000188:drug therapy; D008297:Male; D008545:Melanoma / Q000188:drug therapy; D008875:Middle Aged; D055728:Primary Myelofibrosis / Q000188:drug therapy; D005719:gamma-Globulins / Q000032:analysis*
D001779:Blood Coagulation Factors; D001798:Blood Proteins; D007136:Immunoglobulins; D005719:gamma-Globulins; D001215:Asparaginase
Gerinnungs- und Immunproteinveränderungen unter L-Asparaginasetherapie.